| Ticker | CORT |
|---|---|
| ISIN | US2183521028 |
| Sector | Atención sanitaria |
| Mercado | NASDAQ |
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have failed surgery or are not candidates for surger...
El precio actual de Corcept Therapeutics Incorporated (CORT) es de 46,06 , con una variación del 2,17%.
Corcept Therapeutics Incorporated opera en el sector Healthcare, industria Biotechnology.